Abbott enters agreement with Genentech, Roche and OSI to develop gene test for Tarceva March 12, 2008
Positive interim data for Sunesis' lead product candidate in platinum-resistant ovarian cancer March 12, 2008
Multiple targeting yields enhanced preclinical antitumor effects in head and neck cancer March 12, 2008
BioCancell submits pre-IND application to FDA for phase I clinical trials of BC-819 in cancer March 11, 2008
Genta enters worldwide licensing agreement with Daiichi Sankyo for taxane drug tesetaxel March 10, 2008